News: Medicine

View:
 

Found press releases

 

Minnesota Physician Maya Babu Elected to the AMA Board of Trustees

CHICAGO - June 18, 2013 - The American Medical Association (AMA) today announced Maya Babu, M.D., MBA, a resident in neurosurgery in Rochester, Minn., has been elected to the AMA Board of Trustees. Dr. Babu’s election to the resident position on the board was confirmed at the AMA Annual Meeting.
 
“I am thrilled and honored to serve as the resident representative on the AMA’s Board of Trustees, and I will be a...

AMA ADOPTS NEW POLICIES ON SECOND DAY OF VOTING AT ANNUAL MEETING

CHICAGO – The American Medical Association (AMA), the nation’s largest physician organization, voted today during its Annual Meeting to adopt the following new policies on emerging issues in public health and science:

OPPOSITION TO GENETIC DISCRIMINATION
The AMA today adopted policy strongly opposing discrimination based on an individual’s genetic information. The Genetic Information Nondiscrimination Act (GINA)...

South Carolina Physician Gerald E. Harmon, M.D., Elected to American Medical Ass...

CHICAGO - June 18, 2013 - The American Medical Association (AMA), the nation’s largest physician organization, announced today the election of Gerald E. Harmon, M.D., a family medicine specialist from coastal South Carolina, to the Board of Trustees.
“I am honored to serve the nation’s physicians as a member of the AMA Board of Trustees,” said Dr. Harmon. “Working together, physicians can share our expertise to help...

MISSOURI DOCTOR RE-ELECTED TO AMA BOARD OF TRUSTEES

CHICAGO - June 18, 2013 - David O. Barbe, M.D., MHA, a family physician from Mountain Grove, Mo., was elected today to a second term on the governing board of the American Medical Association (AMA), the nation’s largest physician organization. Dr. Barbe was re-elected by physicians and medical students who were gathered in Chicago for the 2013 AMA Annual Meeting.
“It is a great honor to continue serving on the AMA’s...

Robert M. Wah, M.D., Elected President-Elect of AMA

Retired Navy medical corp captain will become AMA president in June 2014
CHICAGO - June 18, 2013 - Robert M. Wah, M.D., a reproductive endocrinologist and ob-gyn in the Washington, D.C. area, has been elected president-elect of the American Medical Association, the nation’s largest physician organization. Dr. Wah will serve as president-elect for one year and be sworn in as AMA president in June 2014.
“I...

MEDIA ADVISORY

AMA Annual Meeting Begins Second Voting Session Today at 9 am (CT)
Nation’s physicians gather to lead discussion on emerging medical and public health issues
The nation’s broadest assembly of physicians and medical student gather today in Chicago to shape the health care agenda of the American Medical Association (AMA), the country’s largest physician organization.

The AMA’s House of Delegates is the...

AMA Adopts New Policies on First Day of Voting at Annual Meeting

CHICAGO - June 17, 2013 - The American Medical Association (AMA), the nation’s largest physician organization, voted today during its Annual Meeting to adopt the following new policies:

Delivery of Care and Financing Reform for Medicare and Medicaid Dually Eligible Patients
In 2011, approximately $300 billion was spent by the federal government and states for individuals who qualify for both Medicare and Medicaid....

AMA: High Court Sides with Greater Oversight of Pay-For-Delay Agreements

Statement attributable to: Jeremy A. Lazarus, M.D., President, American Medical Association
"The American Medical Association applauds the U.S. Supreme Court ruling today confirming that the Federal Trade Commission has the authority to challenge anti-competitive market barriers that deny patients access to affordable generic medications. There must be oversight of drug manufacturers as they increasingly use...

MEDIMMUNE, ASTRAZENECA’S BIOLOGICS ARM, AND NGM BIOPHARMACEUTICALS ANNOUNCE AGRE...

17 June 2013

AstraZeneca today announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have entered into an exclusive agreement to discover, develop and commercialise novel therapeutics from NGM’s enteroendocrine cell (EEC) programme for the treatment of type 2 diabetes and obesity.

EECs represent less than 1% of all gastrointestinal (GI) cells, but produce...

First patient dosed in new phase III study targeted towards a future clinical in...

Uppsala, Sweden – June 17, 2013 - Orexo AB announces today that the first patient has been dosed with Zubsolv in a phase III study for a new clinical indication for Zubsolv.

Currently all buprenorphine/naloxone combination products licensed in the US are indicated for maintenance treatment only. Following review by the United States Food and Drug Administration (FDA), Orexo has initiated a phase III study, which...